Literature DB >> 2705450

Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus.

D Ellis1, B A Coonrod, J S Dorman, S F Kelsey, D J Becker, E D Avner, T J Orchard.   

Abstract

Twenty-four-hour, four-hour (8 to 12 am), and overnight urine collections were examined for their ability to detect microalbuminuria in 292 patients with insulin-dependent diabetes mellitus (IDDM). Albumin excretion rate (AER) was measured and also estimated from the product of the urinary albumin/creatinine ratio (A/C) and the calculated 24-hour creatinine excretion. The fractional excretion of albumin (FEA) was also determined in aliquots from each urine sample. The correlation coefficients between measured 24-hour AER and estimated AER were 0.940 and 0.956 for four-hour and overnight collections, respectively (significance of each correlation, P less than 0.001). There was no advantage in using the FEA over the A/C ratio in predicting measured AER. Urinary A/C ratios (mg/mg) between 0.03 and 0.31 in the four-hour collections were highly predictive of microalbuminuria and of measured AER in the 24-hour collections: AER24-h (microgram/min/1.73 m2) = 2.74 + 0.870 x A/C4-h (all log10 values). In a subgroup of 175 patients having all three collections validated, 34 (20%) had microalbuminuria defined as AER 20 to 200 micrograms/min/1.73 m2 in at least two of the three samples and 44 (25%) had overt nephropathy (greater than 200 micrograms/min/1.73 m2). The ability of the AER in one urine collection to predict microalbuminuria in at least one of the other two collections was assessed in these 175 patients. Compared with the overnight urine collection, the four-hour collection had greater sensitivity while affording similar specificity and positive predictive value. Based on these data, the A/C ratio from a morning urine sample following initial AM voiding would seem adequate for the detection and monitoring of microalbuminuria in patients with IDDM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705450     DOI: 10.1016/s0272-6386(89)80039-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  33 in total

1.  Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.

Authors:  Katherine V Williams; Dorothy J Becker; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2019-05-31       Impact factor: 2.852

2.  Periodontal disease, smoking, cardiovascular complications and mortality in type 1 diabetes.

Authors:  Tumader Khouja; Rachel G Miller; Paul A Moore; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2019-06-03       Impact factor: 2.852

3.  The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T Costacou; J C Zgibor; R W Evans; J Otvos; M F Lopes-Virella; R P Tracy; T J Orchard
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

4.  Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).

Authors:  Rachel G Miller; Tina Costacou; Trevor J Orchard
Journal:  Diabetes       Date:  2018-11-08       Impact factor: 9.461

5.  Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.

Authors:  Jingchuan Guo; Karen A Nunley; Tina Costacou; Rachel G Miller; Caterina Rosano; Daniel Edmundowicz; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2018-11-08       Impact factor: 5.162

6.  Progression of coronary artery calcium in type 1 diabetes mellitus.

Authors:  Tina Costacou; Daniel Edmundowicz; Catherine Prince; Baqiyyah Conway; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2007-09-27       Impact factor: 2.778

7.  Hemoglobin A1c Level and Cardiovascular Disease Incidence in Persons With Type 1 Diabetes: An Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Am J Epidemiol       Date:  2018-07-01       Impact factor: 4.897

8.  Risk stratification for 25-year cardiovascular disease incidence in type 1 diabetes: Tree-structured survival analysis of the Pittsburgh Epidemiology of Diabetes Complications study.

Authors:  Rachel G Miller; Stewart J Anderson; Tina Costacou; Akira Sekikawa; Trevor J Orchard
Journal:  Diab Vasc Dis Res       Date:  2016-04-21       Impact factor: 3.291

9.  Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.

Authors:  Mark E Molitch; Michael Steffes; Wanjie Sun; Brandy Rutledge; Patricia Cleary; Ian H de Boer; Bernard Zinman; John Lachin
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 19.112

10.  Haptoglobin genotype and renal function decline in type 1 diabetes.

Authors:  Tina Costacou; Robert E Ferrell; Demetrius Ellis; Trevor J Orchard
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.